Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Background Treatment of multi-drug resistant tuberculosis (MDR-TB) for a prolonged period
with comparatively less effective and more toxic second-line anti-TB drugs is associated with …

In a population of Mycobacterium tuberculosis, random chromosomal mutation that results in
genetic resistance to anti‐tuberculosis (TB) drugs occurs at a relatively low frequency. Anti …

To characterize the genetic determinants of resistance to antituberculosis drugs, we
performed a genome-wide association study (GWAS) of 6,465 Mycobacterium tuberculosis …

We investigated the epidemiology of extrapulmonary tuberculosis (TB) among patients
admitted to Bei**g Chest Hospital, Bei**g, China, during January 2008–December 2017. Of …

SETTING: Tuberculosis (TB) program, Damien Foundation Projects, Bangladesh.
OBJECTIVE: To summarize the outcome and its determinants of the first treatment for …

The worldwide emergence of multidrug-resistant (MDR) and extensively drug-resistant
(XDR) tuberculosis threatens to make this disease incurable,. Drug resistance mechanisms …

The rise of drug-resistant strains is a major challenge to containing the tuberculosis (TB)
pandemic. Yet, little is known about the extent of resistance in early years of chemotherapy …

Background The global number of incident cases of multidrug-resistant (MDR) tuberculosis
(TB) in 2000 was estimated to be 272,906 (95% confidence interval [CI], 184,948–414,295) …

The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition
exists is extensively drug-resistant (XDR)-TB. It is not known if additional drug resistance …